Meiji Holdings Co Ltd
TSE:2269
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
|
US |
Intel Corp
NASDAQ:INTC
|
Semiconductors
|
|
US |
Super Micro Computer Inc
NASDAQ:SMCI
|
Technology
|
|
US |
Apple Inc
NASDAQ:AAPL
|
Technology
|
|
US |
NVIDIA Corp
NASDAQ:NVDA
|
Semiconductors
|
|
US |
Alphabet Inc
NASDAQ:GOOGL
|
Media
|
|
US |
Meta Platforms Inc
NASDAQ:META
|
Media
|
|
US |
SoFi Technologies Inc
NASDAQ:SOFI
|
Financial Services
|
|
US |
Microsoft Corp
NASDAQ:MSFT
|
Technology
|
|
US |
Advanced Micro Devices Inc
NASDAQ:AMD
|
Semiconductors
|
|
US |
Amazon.com Inc
NASDAQ:AMZN
|
Retail
|
|
US |
Tesla Inc
NASDAQ:TSLA
|
Automobiles
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3 260
3 802
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Bank of America Corp
NYSE:BAC
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US | |
Intel Corp
NASDAQ:INTC
|
US | |
Super Micro Computer Inc
NASDAQ:SMCI
|
US | |
Apple Inc
NASDAQ:AAPL
|
US | |
NVIDIA Corp
NASDAQ:NVDA
|
US | |
Alphabet Inc
NASDAQ:GOOGL
|
US | |
Meta Platforms Inc
NASDAQ:META
|
US | |
SoFi Technologies Inc
NASDAQ:SOFI
|
US | |
Microsoft Corp
NASDAQ:MSFT
|
US | |
Advanced Micro Devices Inc
NASDAQ:AMD
|
US | |
Amazon.com Inc
NASDAQ:AMZN
|
US | |
Tesla Inc
NASDAQ:TSLA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Meiji Holdings Co Ltd stock under the Base Case scenario is 4 013.24 JPY. Compared to the current market price of 3 299 JPY, Meiji Holdings Co Ltd is Undervalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Meiji Holdings Co Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Meiji Holdings Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Meiji Holdings Co Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Meiji Holdings Co. Ltd., a prominent player in the food and pharmaceutical sectors, was founded in Japan in 1917. Originally emerging as a dairy company, it has successfully expanded its portfolio to encompass a variety of consumer products, ranging from dairy goods and snacks to health supplements and pharmaceuticals. The company’s renowned Meiji brand, cherished both domestically and internationally, has made waves in the market, thanks to its commitment to quality and innovation. With an unwavering focus on research and development, Meiji has positioned itself as a leader in nutritional science, leveraging its expertise to create products that not only taste great but also contribute to h...
Meiji Holdings Co. Ltd., a prominent player in the food and pharmaceutical sectors, was founded in Japan in 1917. Originally emerging as a dairy company, it has successfully expanded its portfolio to encompass a variety of consumer products, ranging from dairy goods and snacks to health supplements and pharmaceuticals. The company’s renowned Meiji brand, cherished both domestically and internationally, has made waves in the market, thanks to its commitment to quality and innovation. With an unwavering focus on research and development, Meiji has positioned itself as a leader in nutritional science, leveraging its expertise to create products that not only taste great but also contribute to health and wellness.
For investors, Meiji Holdings represents a compelling opportunity against a backdrop of growing trends in health consciousness and dietary needs. The company boasts a strong financial track record, evidenced by steady revenue growth and healthy profit margins, which reflect its operational efficiency and customer loyalty. Furthermore, Meiji's proactive strategies in expanding its global footprint, particularly in emerging markets, highlight its potential for future growth. As consumer preferences increasingly gravitate towards nutritious and convenient food options, Meiji’s rich history and dedication to excellence make it an appealing investment for those looking to capitalize on the evolving landscape of food and health industries.
Meiji Holdings Co., Ltd. is a leading Japanese company well-known for its involvement in the food and pharmaceutical sectors. The core business segments of Meiji Holdings can be summarized as follows:
-
Dairy Products: This segment includes the production of dairy items such as milk, yogurt, cheese, and other dairy-based products. Meiji is recognized for its high-quality dairy products and innovative offerings, catering to both consumer and business markets.
-
Nutrition: Meiji's nutrition segment focuses on health and wellness products, including infant formula, nutritional supplements, and other food products specially formulated for dietary needs. This segment has seen growth due to increasing health awareness among consumers.
-
Confectionery and Snacks: This segment encompasses a variety of confectionery products, including chocolates, candies, and snack foods. Meiji has a strong brand presence in the sweets market, appealing to diverse consumer preferences.
-
Pharmaceuticals: Meiji Holdings operates in the pharmaceutical industry, developing and manufacturing prescription drugs and vaccines. This segment plays a crucial role in the company's overall portfolio, contributing to public health and healthcare advancements.
-
Other Food Products: Apart from dairy and confectionery, Meiji also engages in other food product categories, such as processed foods. This includes items like sauces, seasonings, and ready-to-eat meals.
These segments allow Meiji Holdings to leverage its expertise in food science and technology while maintaining a strong market position through innovation and quality assurance. The company continues to explore growth opportunities in line with consumer trends and health-focused markets.
Meiji Holdings Co., Ltd., known for its diversified portfolio in dairy products, confectionery, and pharmaceuticals, possesses several unique competitive advantages that distinguish it from its competitors:
-
Strong Brand Recognition: Meiji has established a strong brand presence in Japan and other markets. Its reputation for quality, particularly in dairy and children's nutrition, helps it retain customer loyalty.
-
Diverse Product Line: The company's broad product range includes dairy products, chocolate, and nutritional supplements. This diversification reduces dependency on a single market segment, allowing the company to mitigate risks associated with market fluctuations.
-
Research and Development: Meiji invests significantly in R&D, enabling it to innovate and improve its products continuously. The focus on health-conscious offerings, such as functional foods, positions it well in a market trending towards health and wellness.
-
Strong Supply Chain Management: Meiji maintains a robust supply chain and strong relationships with suppliers, ensuring high-quality raw materials and reliable product availability. This leads to better cost control and efficiency.
-
Sustainability Initiatives: The company emphasizes sustainable practices, particularly in agriculture and manufacturing. This commitment enhances its brand reputation and appeals to increasingly environmentally-conscious consumers.
-
Market Expertise: With decades of experience in the industry, Meiji possesses significant market knowledge and insights that help it respond quickly to consumer trends and preferences.
-
Strategic Partnerships and Acquisitions: Meiji has engaged in strategic partnerships and acquisitions that broaden its market presence and enhance its capabilities, particularly in the global market.
-
Focus on Nutrition: The company has a strong emphasis on health-oriented products, which is aligned with global trends towards nutrition and wellness. This focus allows it to cater effectively to health-conscious consumers.
-
Innovative Marketing Strategies: Meiji utilizes creative marketing approaches that resonate with different consumer segments, including children and health-focused adults, which strengthens its market penetration.
By leveraging these competitive advantages, Meiji Holdings can maintain a strong position in both domestic and international markets, helping it to outperform rivals in various sectors.
Meiji Holdings Co., Ltd., as a major player in the food and pharmaceutical industries, faces several potential risks and challenges in the near future:
-
Market Competition: The food and pharmaceutical sectors are highly competitive. New entrants and existing competitors may introduce innovative products or aggressive pricing strategies, which can pressure Meiji's market share and margins.
-
Supply Chain Disruptions: Global supply chain issues, exacerbated by recent geopolitical tensions or pandemics, can affect the availability of raw materials and packaging. This can lead to increased costs and potential delays in production.
-
Regulatory Challenges: Changes in regulations related to food safety, pharmaceutical approvals, and labeling can impose additional compliance burdens and costs. Navigating these regulations while ensuring product safety and effectiveness is crucial.
-
Health Trends: There is a growing consumer trend towards health-conscious products and sustainability. If Meiji fails to adapt its product offerings to meet these trends, it could lose relevancy in the market.
-
Economic Fluctuations: Macroeconomic factors, such as inflation, currency fluctuations, and changes in consumer spending power, can impact sales. For instance, a downturn in the economy may lead to reduced demand for premium products.
-
Technological Advancements: The rapid pace of technological change in food production and pharmaceuticals presents both opportunities and risks. Failure to innovate or adopt new technologies could hinder Meiji's competitive position.
-
Raw Material Costs: Fluctuations in the prices of key ingredients, driven by factors such as climate change or trade policies, can impact profit margins. Hedging or long-term contracts may mitigate this risk but may not eliminate it entirely.
-
Consumer Preferences: Changes in consumer preferences can shift demand significantly. If Meiji is unable to keep pace with these changes, particularly in terms of health-oriented or plant-based products, it could lose market share.
-
Brand Reputation: As a well-known brand, any negative publicity regarding product safety, quality issues, or unethical practices can severely impact consumer trust and sales.
-
International Expansion Risk: If Meiji pursues growth in international markets, it faces various risks including adapting to local tastes, navigating different regulatory landscapes, and potential political instability in those regions.
Mitigating these risks will require strategic planning, investment in R&D, a strong focus on consumer trends, and effective supply chain management. Continuous monitoring of the market and proactive adaptation will be crucial for sustaining growth and profitability.
Revenue & Expenses Breakdown
Meiji Holdings Co Ltd
Balance Sheet Decomposition
Meiji Holdings Co Ltd
Current Assets | 556.7B |
Cash & Short-Term Investments | 90.9B |
Receivables | 199.2B |
Other Current Assets | 266.6B |
Non-Current Assets | 646.1B |
Long-Term Investments | 82B |
PP&E | 487B |
Intangibles | 21.4B |
Other Non-Current Assets | 55.7B |
Current Liabilities | 317.2B |
Accounts Payable | 121.4B |
Accrued Liabilities | 40.3B |
Short-Term Debt | 20B |
Other Current Liabilities | 135.5B |
Non-Current Liabilities | 136.1B |
Long-Term Debt | 26.6B |
Other Non-Current Liabilities | 109.5B |
Earnings Waterfall
Meiji Holdings Co Ltd
Revenue
|
1.1T
JPY
|
Cost of Revenue
|
-788.4B
JPY
|
Gross Profit
|
333.1B
JPY
|
Operating Expenses
|
-247.8B
JPY
|
Operating Income
|
85.3B
JPY
|
Other Expenses
|
-32.3B
JPY
|
Net Income
|
53B
JPY
|
Free Cash Flow Analysis
Meiji Holdings Co Ltd
JPY | |
Free Cash Flow | JPY |
The company posted a robust first half with a JPY 546 billion in net sales and a JPY 44.4 billion in operating profit, surpassing the initial forecast by JPY 12.4 billion and marking year-on-year growth. Meanwhile, net income reached JPY 27.9 billion despite a share of loss and higher tax expenses. The positive results led to a dividend hike for the 10th consecutive year. While second-half profit is projected to be above initial plans due to lower costs, full-year expectations for sales and profits in the Pharmaceutical segment were revised down. The decrease reflects higher R&D expenses and the non-contribution of the ARCT-154 COVID-19 vaccine. Yet, with strong antibacterial drug sales, the company aims to at least meet its current forecast.
What is Earnings Call?
Profitability Score
Profitability Due Diligence
Meiji Holdings Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Meiji Holdings Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Meiji Holdings Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Score
Meiji Holdings Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Meiji Holdings Co Ltd
According to Wall Street analysts, the average 1-year price target for Meiji Holdings Co Ltd is 3 584.57 JPY with a low forecast of 3 131 JPY and a high forecast of 3 990 JPY.
Dividends
Current shareholder yield for Meiji Holdings Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Meiji Holdings Co., Ltd. engages in the management of its subsidiaries with business activities focusing on food and pharmaceutical production. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 17,832 full-time employees. The company went IPO on 2009-04-01. The firm operates its business through two business segments. The Food segment is involved in the manufacture and sale of yogurt, milk, beverages, cheese, butter, margarine, cream, ice cream, frozen food, chocolate, gummi, gum, sports nutrition, powdered milk, liquid food, beauty food, general medicine, sugar, saccharified flour and others. The Pharmaceuticals segment is involved in the manufacture and sale of ethical pharmaceuticals, agricultural chemicals and animal drugs.
Contact
IPO
Employees
Officers
The intrinsic value of one Meiji Holdings Co Ltd stock under the Base Case scenario is 4 013.24 JPY.
Compared to the current market price of 3 299 JPY, Meiji Holdings Co Ltd is Undervalued by 18%.